House Bill

HB 1065

Cancer clinical trial program.

In plain English

Allows an organization or entity to set up a program that pays participants for certain costs they have while taking part in a cancer clinical trial. Sets requirements for how the program must operate and who is eligible to take part.

Written by AI from the official digest below, and checked only by automated rules. If they differ, the official digest and bill text control.

Official digest

Allows an organization or entity to establish and administer a cancer clinical trial participation program for the purpose of providing payments to a participant for certain costs incurred by the participant while participating in a cancer clinical trial. Sets forth program requirements and participant eligibility.

Latest action: Signed by the Governor, April 3, 2025Full text and history at iga.in.gov

Authors and sponsors

Robin Shackleford, Ed Charbonneau, Michael Crider, Shelli Yoder

Co-authors and co-sponsors: Brad Barrett, Mike Aylesworth, Gregory Porter, La Keisha Jackson, Lonnie Randolph

Roll-call votes

2 recorded votes, oldest first. Third-reading votes decide whether a bill passes a chamber; amendment votes and procedural motions are listed too.

House · Feb 17, 2025

Third reading: vote to pass

Roll call text: HB 1065 - Shackleford - 3rd Reading

Passed

95 yes0 no5 did not vote

Republicans: 66 yes, 0 no, 4 did not voteDemocrats: 27 yes, 0 no, 1 did not voteIndependents: 1 yes, 0 noNot matched to a current member: 1 yes, 0 no

How each member voted

Yes (95)

Did not vote (5)

Senate · Mar 18, 2025

Third reading: vote to pass

Roll call text: HB 1065 - Charbonneau - 3rd Reading

Passed

49 yes0 no1 did not vote

Republicans: 38 yes, 0 no, 1 did not voteDemocrats: 10 yes, 0 noNot matched to a current member: 1 yes, 0 no

How each member voted

Source: Open States, compiled from the Indiana General Assembly's official roll calls. The official record at iga.in.gov controls. Spot an error? Let us know.